Table 2. Outcomes and clinical course.
| Mortality | 4 (13) | ||
| LOS in-hospital after VATS (days), median (IQR) | 8 (5–14) | ||
| Additional VATS needed | 7 (23) | ||
| Operative data during VATS | |||
| Operation time (min), median (IQR) | 120 (90–143) | ||
| PRBCs (units), median (IQR)† | 0 (0–1) | ||
| FFPs (units), median (IQR)† | 0 (0–0) | ||
| PCs (units), median (IQR)† | 0 (0–0) | ||
| Inotropes needed | 2 (7) | ||
| Complications after VATS | |||
| Sternal rewiring | 1 (3) | ||
| Complicated wound healing | 0 (0) | ||
| Pneumonia/bronchitis | 6 (20) | ||
| Septic shock | 4 (13) | ||
| Acute kidney failure needing dialysis | 6 (20) | ||
| Pulmonary artery embolism | 0 (0) | ||
| Ischemic stroke | 0 (0) | ||
| Hemorrhagic stroke | 0 (0) | ||
| Gastrointestinal bleeding | 1 (3) | ||
| Airway bleeding | 0 (0) | ||
| Pericardial tamponade | 0 (0) | ||
| Delirium | 5 (17) | ||
| Laboratory parameters before discharge/death | |||
| Hb (g/dL), median (IQR) | 9.3 (8.6–10) | ||
| Leucocytes (/nL), median (IQR) | 8.9 (6.2–10.3) | ||
| Platelet (G/L), median (IQR) | 272 (189–447) | ||
| PCT (ng/mL), median (IQR) | 0.15 (0.08–0.49) | ||
| INR (ratio), median (IQR) | 1.1 (0.37–1.24) | ||
| LDH (U/L), median (IQR) | 306 (256–340) | ||
| AST (U/L), median (IQR) | 44 (24–70) | ||
| ALT (U/L), median (IQR) | 39 (18–67) | ||
| Creatinine (mg/dL), median (IQR) | 0.90 (0.66–1.43) | ||
| BUN (mg/dL), median (IQR) | 42 (25–77) | ||
Percentages are shown in parentheses unless indicated as IQR.
†Including all units used on the day of VATS. ALT: alanine transaminase; AST: aspartate transaminase; BUN: blood urea nitrogen; FFP: fresh frozen plasma; ICU: intensive care unit; IQR: interquartile range; LDH: lactate dehydrogenase; LOS: length of stay; PC: platelet concentrate; PCT: procalcitonin; PRBC: packed right blood cells; VATS: video- assisted thoracic surgery